BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 2409140)

  • 21. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions.
    Spits H; Paliard X; De Vries JE
    J Immunol; 1989 Sep; 143(5):1506-11. PubMed ID: 2474601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM; McKenzie RS; Simms PE; Helfrich BA; Fisher RI
    J Immunol; 1989 Dec; 143(12):4282-6. PubMed ID: 2512355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinate expression of cytolytic activity and cytotoxic T cell-specific carbohydrate antigens in a T cell hybridoma.
    Lefrancois L; Kanagawa O
    J Immunol; 1986 Feb; 136(4):1171-7. PubMed ID: 2418106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.
    Simon MM; Hochgeschwender U; Brugger U; Landolfo S
    J Immunol; 1986 Apr; 136(8):2755-62. PubMed ID: 3082972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N; Tokura Y; Takigawa M; Egawa K
    J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
    Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
    Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.
    Takai Y; Herrmann SH; Greenstein JL; Spitalny GL; Burakoff SJ
    J Immunol; 1986 Dec; 137(11):3494-500. PubMed ID: 3097123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of interleukin 3 but not interleukin 2 or interferon production in the syngeneic mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Igarashi M; Kumagai K
    J Immunol; 1986 Sep; 137(5):1564-72. PubMed ID: 2427574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H; Yssel H; Paliard X; Kastelein R; Figdor C; de Vries JE
    J Immunol; 1988 Jul; 141(1):29-36. PubMed ID: 2454260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.
    Brooks CG; Holscher M
    J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary in vitro generation of CTL specific for MM antigen by stimulation with somatic tumor hybrid, but not with parental tumor cells.
    Ishikawa S; Tachibana T
    J Immunol; 1983 Oct; 131(4):2059-63. PubMed ID: 6194225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G
    J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.